This chimeric antibody binds to CD25 expressed in CHO cells. It has been evaluated in a phase I/II clinical study for human renal transplantation with promising results. The antibody is chimeric human/mouse IgG that was tested to bind specifically to native human CD25. It has been reported for use in functional and blocking assays, though the optimal conditions need to be determined for specific assays.